Governing Health

The supervision, compensation and retention of senior executive leadership is an increasingly pressing issue for boards of directors. On this episode, the second in a two-part series, Michael Peregrine welcomes John Challenger, CEO of outplacement firm Challenger, Gray & Christmas, and Ralph DeJong, partner at McDermott Will & Emery, to discuss the uptick in CEO turnover levels. This dynamic episode explores how CEO retention issues influence the decision-making process of the executive compensation committee and other board committees.

An increasingly critical duty for boards of directors relates to the supervision, compensation and retention of the senior executive leadership team. On this episode, the first in a two-part series, Michael Peregrine welcomes Tim Cotter, managing director of SullivanCotter, and Ralph DeJong, partner at McDermott Will and Emery, for a discussion on the latest trends and developments impacting the executive compensation committee's decision-making process.

Corporate governance is influenced by a wide range of government regulations, legislative initiatives, stakeholder and public demands, responsibilities to investors and case law. On this episode, Michael Peregrine welcomes Professor Charles Elson, Director of the John L. Weinberg Center for Corporate Governance, for a discussion on the complexities of corporate law and governance today. Mr. Elson's perspective on corporate governance best practices and recent cases from the Delaware courts will benefit directors of public, private and nonprofit corporations alike, and reminds us that the law of corporate governance is constantly evolving and being extended in new and different ways.

In the rapidly transforming healthcare environment, “consumerism” presents an increasingly critical board oversight challenge. This extends well past the adoption of new technology to improve the patient experience—it’s really about healthcare providers understanding the patient’s perspective and rethinking their approach to doing business accordingly. To help healthcare leaders understand the business and fiduciary implications of this shift toward consumerism, Michael Peregrine welcomes Dan Clarin and Rob Fromberg to the podcast, two of the experts behind Kaufman Hall’s 2019 State of Consumerism in Healthcare Report.

While most healthcare companies actively work to promote their ethical standards and values, in a time of rapid industry transformation these codes of ethics can quickly grow stale. In the latest episode of the Governing Health podcast, Michael Peregrine welcomes Chris White, Chief Operating Officer and General Counsel of AdvaMed, to discuss AdvaMed’s bold action to revise its longstanding code of ethics, and the broad healthcare industry significance of the new AdvaMed Code.

The successful operation of the board’s Audit Committee and its ability to keep up to date with the latest developments is critical to corporate oversight. Given the significant responsibilities imposed on it, however, the Committee can easily become overburdened. Michael Peregrine welcomes Scott Steffens and Mary Torretta of Grant Thornton to help bring some clarity to the Audit Committee’s agenda.

Directors are constantly focused on the exercise of their fiduciary duties; what they are and how they should be applied. For nonprofit boards, the state attorney general has a similar interest, for the AG has primary jurisdiction over how nonprofit directors exercise their duties. In the latest episode of Governing Health, Michael Peregrine welcomes back Jim Sheehan, Chief of the New York Attorney General’s Charities Bureau, to discuss key issues pertaining to the AGs role in monitoring non-profit health care governance.

Economic trends and indicators have significant implications for health care boards. In the latest episode of the Governing Health podcast, Michael Peregrine welcomes back John Challenger, CEO of executive outplacement firm Challenger, Gray & Christmas, to discuss what the finance, human resources, executive compensation and succession planning committees should consider.

As health system boards pursue transformative opportunities in response to the pressures of disruption, innovation and evolution in delivery models, they are pushed outside of their historical comfort zone. The stakes are high: the radical decisions made today will have lasting and dramatic impacts on the sustainability of the organization. The board must take significant risks, embrace major mission shifts and execute within challengingly short windows of opportunity. Learn more about Radical Decision-Making in the two-part Governing Health podcast series, brought to you by McDermott and KaufmanHall. Visit www.mwe.com/governinghealth.

Health care organizations seeking to respond to disruption, digital innovation and evolution in delivery models are consolidating at a rapid pace. These initiatives often involve significant risks, major mission shifts and challengingly short windows of opportunity—and the board's traditional approach to decision-making increasingly falls short. Can the health system board move fast enough to make radical decisions that respond to business disruption, yet are still grounded in duty of care principles?